Home LiteratureArticle Details
PMID: 20208017 Published · ppublish English Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.

Journal of the National Cancer Institute ·Vol. 102 ·No. 6 ·2010-03-17 ·Pages 391-400

Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martínez ME, Colon Cancer Family Registry

Abstract

Being overweight or obese is an established risk factor for colorectal cancer, more so for men than for women. Approximately 10%-20% of colorectal tumors display microsatellite instability (MSI), defined as the expansion or contraction of small repeated sequences in the DNA of tumor tissue relative to nearby normal tissue. We evaluated associations between overweight or obesity and colorectal cancer risk, overall and by tumor MSI status. The study included 1794 case subjects with incident colorectal cancer who were identified through population-based cancer registries and 2684 of their unaffected sex-matched siblings as control subjects. Recent body mass index (BMI), BMI at age 20 years, and adult weight change were derived from self-reports of height and weight. Tumor MSI status, assessed at as many as 10 markers, was obtained for 69.7% of the case subjects and classified as microsatellite (MS)-stable (0% of markers unstable; n = 913), MSI-low (>0% but <30% of markers unstable; n = 149), or MSI-high (> or =30% of markers unstable; n = 188). Multivariable conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs). All statistical tests were two-sided. Recent BMI, modeled in 5 kg/m(2) increments, was positively associated with risk of colorectal cancer for men and women combined (OR = 1.24; 95% CI = 1.15 to 1.34), for women only (OR = 1.20; 95% CI = 1.10 to 1.32), and for men only (OR = 1.30; 95% CI = 1.15 to 1.47). There was no interaction with sex (P = .22). Recent BMI, per 5 kg/m(2), was positively associated with the risk of MS-stable (OR = 1.38; 95% CI = 1.24 to 1.54) and MSI-low (OR = 1.33; 95% CI = 1.04 to 1.72) colorectal tumors, but not with the risk of MSI-high tumors (OR = 1.05; 95% CI = 0.84 to 1.31). The increased risk of colorectal cancer associated with a high BMI might be largely restricted to tumors that display the more common MS-stable phenotype, suggesting further that colorectal cancer etiology differs by tumor MSI status.

MeSH Terms
Adult African Americans/genetics,statistics & numerical data Aged Body Mass Index Case-Control Studies Colorectal Neoplasms/epidemiology,ethnology,etiology,genetics Confounding Factors, Epidemiologic Female Humans Indians, North American/genetics,statistics & numerical data Life Style Logistic Models Male Microsatellite Instability Middle Aged Multivariate Analysis Obesity/complications Odds Ratio Overweight/complications Risk Assessment Risk Factors Weight Gain Whites/genetics,statistics & numerical data
Authors & Affiliations
24 authors, click to expand affiliations / ORCID
Campbell Peter T
Epidemiology Research Program, American Cancer Society, National Home Office, 250 Williams St NW, Atlanta, GA 30303, USA. peter.campbell@cancer.org.
Jacobs Elizabeth T
Ulrich Cornelia M
Figueiredo Jane C
Poynter Jenny N
McLaughlin John R
Haile Robert W
Jacobs Eric J
Newcomb Polly A
Potter John D
Le Marchand Loïc
Green Roger C
Parfrey Patrick
Younghusband H Banfield
Cotterchio Michelle
Gallinger Steven
Jenkins Mark A
Hopper John L
Baron John A
Thibodeau Stephen N
Lindor Noralane M
Limburg Paul J
Martínez María Elena
Colon Cancer Family Registry
References (41)
41 references, click to expand
  1. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity.
    Diabetes. 2002 Apr;51(4):1093-101 PMID: 11916931
  2. Validity of self-reported height and weight in 4808 EPIC-Oxford participants.
    Public Health Nutr. 2002 Aug;5(4):561-5 PMID: 12186665
  3. Diet, cancer and aging in DNA mismatch repair deficient mice.
    Carcinogenesis. 2002 Nov;23(11):1807-10 PMID: 12419828
  4. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
    N Engl J Med. 2003 Jul 17;349(3):247-57 PMID: 12867608
  5. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults.
    Int J Obes Relat Metab Disord. 2004 Apr;28(4):559-67 PMID: 14770200
  6. Selection of controls in case-control studies. II. Types of controls.
    Am J Epidemiol. 1992 May 1;135(9):1029-41 PMID: 1595689
  7. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status.
    Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2745-50 PMID: 19755657
  8. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors.
    J Natl Cancer Inst. 2000 Nov 15;92(22):1831-6 PMID: 11078760
  9. Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas.
    Carcinogenesis. 2001 Oct;22(10):1681-4 PMID: 11577009
  10. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC).
    Cancer Invest. 2002;20(1):102-9 PMID: 11852992
  11. Physical activity, obesity, and risk for colon cancer and adenoma in men.
    Ann Intern Med. 1995 Mar 1;122(5):327-34 PMID: 7847643
  12. Genetic instability in colorectal cancers.
    Nature. 1997 Apr 10;386(6625):623-7 PMID: 9121588
  13. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer.
    Cancer Res. 1997 Nov 1;57(21):4787-94 PMID: 9354440
  14. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum.
    Am J Epidemiol. 1998 Apr 1;147(7):670-80 PMID: 9554606
  15. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
    Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870-5 PMID: 9618505
  16. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
    Cancer Res. 1998 Nov 15;58(22):5248-57 PMID: 9823339
  17. Colorectal cancer: molecules and populations.
    J Natl Cancer Inst. 1999 Jun 2;91(11):916-32 PMID: 10359544
  18. A gene expression signature of genetic instability in colon cancer.
    Cancer Res. 2005 Oct 15;65(20):9200-5 PMID: 16230380
  19. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort.
    Int J Cancer. 2006 Jan 15;118(2):458-66 PMID: 16049963
  20. Influence of obesity on the risk of developing colon cancer.
    Gut. 2006 Feb;55(2):285-91 PMID: 16239255
  21. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes.
    J Nutr Biochem. 2006 Mar;17(3):145-56 PMID: 16426829
  22. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).
    J Natl Cancer Inst. 2006 Jul 5;98(13):920-31 PMID: 16818856
  23. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.
    Histopathology. 2007 Jan;50(1):113-30 PMID: 17204026
  24. Comparison of self-reported and measured BMI as correlates of disease markers in US adults.
    Obesity (Silver Spring). 2007 Jan;15(1):188-96 PMID: 17228047
  25. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
    J Natl Cancer Inst. 2007 Mar 21;99(6):463-74 PMID: 17374836
  26. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies.
    Am J Clin Nutr. 2007 Sep;86(3):556-65 PMID: 17823417
  27. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer.
    Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1735-44 PMID: 17855691
  28. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.
    Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43 PMID: 17982118
  29. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
    Lancet. 2008 Feb 16;371(9612):569-78 PMID: 18280327
  30. Obesity and cancer: pathophysiological and biological mechanisms.
    Arch Physiol Biochem. 2008 Feb;114(1):71-83 PMID: 18465361
  31. Biological activity and clinical implications of the matrix metalloproteinases.
    Anticancer Res. 2008 Mar-Apr;28(2B):1389-97 PMID: 18505085
  32. Prospective weight change and colon cancer risk in male US health professionals.
    Int J Cancer. 2008 Sep 1;123(5):1160-5 PMID: 18546286
  33. Effects of measurement on obesity and morbidity.
    Health Rep. 2008 Jun;19(2):77-84 PMID: 18642521
  34. A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence.
    Cancer Causes Control. 2008 Sep;19(7):783-92 PMID: 18322811
  35. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
    J Clin Oncol. 2008 Sep 1;26(25):4109-15 PMID: 18757324
  36. The adipocyte as an endocrine cell.
    Endocrinol Metab Clin North Am. 2008 Sep;37(3):753-68, x-xi PMID: 18775362
  37. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
    Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3208-15 PMID: 18990764
  38. Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice.
    Int J Obes (Lond). 2008 Nov;32(11):1716-9 PMID: 18725892
  39. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study.
    Am J Epidemiol. 2009 Mar 15;169(6):657-66 PMID: 19147743
  40. Obesity and weight gain in adulthood and telomere length.
    Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):816-20 PMID: 19273484
  41. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.
    N Engl J Med. 2000 Jan 13;342(2):69-77 PMID: 10631274
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
1460-2105
Published
2010-03-17
Epub
2010-00-05
Pages
391-400
Language
English
Region
United States
NLM ID
7503089
PMCID
PMC2841037
Subset
IM
Grants
NCI NIH HHS · U01 CA074799 · United States
NCI NIH HHS · 1K07CA10629-01A1 · United States
NCI NIH HHS · CA041108-19 · United States
NCI NIH HHS · RFA CA-95-011 · United States
NCI NIH HHS · U54 CA116847 · United States
CIHR · CRT-43821 · Canada
NCI NIH HHS · U01 CA074794 · United States
NCI NIH HHS · T32 CA009142 · United States
NCI NIH HHS · U01 CA097735 · United States
NCI NIH HHS · U01 CA074783 · United States
CIHR · CRT-79845 · Canada
NCI NIH HHS · U01 CA074806 · United States
NCI NIH HHS · U01 CA074800 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com